导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.20% | 438/1050 |
| 近一周 | -0.78% | 414/1104 |
| 近一月 | -2.04% | 364/1103 |
| 近一季 | -7.32% | 585/1092 |
| 近半年 | -3.87% | 588/1070 |
| 近一年 | 6.99% | 434/1018 |
| 近两年 | 71.29% | 359/926 |
| 近三年 | 45.69% | 298/834 |
| 成立以来 | 100.59% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.42% 233/1070 |
12.85% 501/1101 |
- - |
- - |
| 2025 | 32.76% 430/1065 |
2.35% 616/1014 |
3.08% 431/1038 |
26.18% 425/1050 |
-0.27% 471/1065 |
| 2024 | 13.66% 206/1011 |
7.66% 53/960 |
-5.12% 643/983 |
11.62% 492/991 |
-0.31% 340/1011 |
| 2023 | -7.16% 258/952 |
3.66% 396/880 |
-2.59% 344/895 |
-1.10% 119/915 |
-7.03% 680/952 |
| 2022 | -12.95% 133/867 |
-8.89% 84/773 |
2.52% 648/806 |
-8.92% 192/845 |
2.33% 308/867 |
| 2021 | 10.21% 247/740 |
3.12% 77/580 |
3.77% 488/659 |
3.87% 150/704 |
-0.84% 475/740 |
| 2020 | 29.22% 352/554 |
-3.53% 249/419 |
15.00% 353/466 |
6.32% 339/517 |
9.55% 371/554 |
| 2019 | 23.08% 325/410 |
24.83% 714/1146 |
-6.04% 781/1228 |
-2.04% 360/390 |
7.12% 271/410 |
| 2018 | - - |
- - |
- - |
-1.84% 299/1000 |
-12.03% 584/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 博时量化价值股票C VS. 东吴新产业精选股票A(580008) |